J. R. Lombardo

Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells

S. Mandl, R. Rountree, R. Steigerwald, 2011, Cancer Immunology, Immunotherapy.

Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.

S. Mandl, R. Rountree, A. Delcayre, 2011, Cancer research.

Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model

D. Chao, G. Starling, D. Law, 2009, Journal of Neuroimmunology.